Noninvasive monitoring of low-grade prostate cancer with a urinary biomarker test could reduce the need for biopsies and serial imaging, according to a study ...

Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You ...

Upon reviewing repeated prostate cancer screenings, researchers observed the absence of suspicious MRI findings in over 86% of men who had prostate-specific antigen (PSA) levels of 3 ng/mL or higher ...

A new urine test performed better than PSA-based testing and MRI for monitoring low-risk prostate cancers on active ...

A large screening trial showed that using prostate-specific antigen density (PSAD) before MRI prevented overdiagnosis and lowered resource use while preserving the detection of clinically significant ...

Scans that makes prostate cancer cells "glow" could cut the need for invasive biopsies, according to new research. The state-of-the-art imaging test could safely halve the number of men who need to ...

Targeting men in the top 10% of genetic risk helped detect high-grade prostate cancer that conventional screening would miss, paving the way for more personalized and effective early detection ...

Prostate cancer is one of the top diagnoses for men with cancer, but early stages are tough to detect.

A major review of nearly 800,000 men has found prostate cancer screening using a specific test is likely to reduce deaths ...